HCID 67314324, compound → HCID 67313969, compound
Reaction equation
C(OC([N:11]1[CH2:16][CH2:15][CH:14]([CH:17]([C:19]2[CH:24]=[CH:23][C:22]([C@@H:25]([NH:27][C:28]3[N:33]=[C:32]([C:34]4[N:38]5[CH:39]=[CH:40][CH:41]=[C:42]([CH2:43][CH3:44])[C:37]5=[N:36][CH:35]=4)[C:31]([C:45]#[N:46])=[CH:30][N:29]=3)[CH3:26])=[CH:21][CH:20]=2)[OH:18])[CH2:13][CH2:12]1)=O)C1C=CC=CC=1>C(O)C.[OH-].[Pd+2].[OH-]>[CH2:43]([C:42]1[C:37]2[N:38]([C:34]([C:32]3[C:31]([C:45]#[N:46])=[CH:30][N:29]=[C:28]([NH:27][C@H:25]([C:22]4[CH:21]=[CH:20][C:19]([CH:17]([OH:18])[CH:14]5[CH2:13][CH2:12][NH:11][CH2:16][CH2:15]5)=[CH:24][CH:23]=4)[CH3:26])[N:33]=3)=[CH:35][N:36]=2)[CH:39]=[CH:40][CH:41]=1)[CH3:44]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
118 mg of the compound [25-2] was dissolved in 4 mL of ethanol, then 50 mg of a carbon catalyst of 20% palladium hydroxide was added thereto, and the mixture was stirred overnight at room temperature under hydrogen atmosphere. The catalyst was filtered through celite, the filtrate was concentrated under reduced pressure, and then the resulting residue was purified by preparative thin-layer chromatography, to obtain 66 mg of 4-(8-ethylimidazo[1,2-a]pyridin-3-yl)-2-[((1S)-1-{4-[hydroxy(piperidin-4-yl)methyl]phenyl}ethyl)amino]pyrimidine-5-carbonitrile [25-3] (hereinafter, referred to as the compound [25-3]).
Workup
- filtrationThe catalyst was filtered through celite
- concentrationthe filtrate was concentrated under reduced pressure
- customthe resulting residue was purified by preparative thin-layer chromatography
Sources & evidence
- ORD record
- ord-320f806d193743b391383f63318e8aa8
- Source dataset
- uspto-grants-2011_07
- Patent number
- US07977336B2
Reaction notes
Loading…